Cite
HARVARD Citation
Mathew Thomas, V. et al. (2020). Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor. Journal of oncology pharmacy practice. pp. 459-461. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mathew Thomas, V. et al. (2020). Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor. Journal of oncology pharmacy practice. pp. 459-461. [Online].